CYTOGENETICS OF 158 PATIENTS WITH REGIONAL OR DISSEMINATED MELANOMA - SUBSET ANALYSIS OF NEAR-DIPLOID AND SIMPLE KARYOTYPES

被引:131
作者
THOMPSON, FH
EMERSON, J
OLSON, S
WEINSTEIN, R
LEAVITT, SA
LEONG, SPL
EMERSON, S
TRENT, JM
NELSON, MA
SALMON, SE
TAETLE, R
机构
[1] UNIV ARIZONA,ARIZONA CANC CTR,TUCSON,AZ 85724
[2] UNIV ARIZONA,DEPT MED,TUCSON,AZ
[3] UNIV ARIZONA,DEPT PATHOL,TUCSON,AZ
[4] UNIV CALIF SAN FRANCISCO,MT ZION MED CTR,DEPT SURG,SAN FRANCISCO,CA 94120
[5] NIH,NATL CTR HUMAN GENOME RES,BETHESDA,MD 20892
关键词
D O I
10.1016/0165-4608(95)00057-V
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We report on the cytogenetic analyses of 158 cases of metastatic malignant melanoma, comprised of 63 cases with regional disease (RD) and 95 cases with distant (metastatic) disease (DD). Clonal structural abnormalities were identified in 126 (80%) cases and were significantly increased (< 0.01 after adjusting for multiple comparisons) on chromosomes fin order of frequency of involvement) 1, 6, 7, 11, 9, and 3. Clustering of breakpoints occurred at 1p36, 1p22-q21, 6p11-q21, 9p, 11q23-qter, 13p (especially for cases with DD), and 19q13. The most common clonal numerical abnormalities, in a subset of 49 near-diploid cases were -10, -22, -9, +7, -19, and -Y. Analysis of chromosome segment gains and losses (CSRP) showed frequent loss of chromosomes 6 and 10, followed by equal rates of involvement of chromosomes 1, 7, and 9. Whole or segmental losses of chromosome 9 (especially 9p) correlate well with recent molecular genetic studies identifying putative suppressor genes, and are also likely important genetic abnormalities. However, based on the frequency of abnormalities in this large series of metastatic melanomas, it is likely that structural abnormalities of 1 and 6, and -10 are important in the pathogenesis of sporadic advanced melanoma.
引用
收藏
页码:93 / 104
页数:12
相关论文
共 64 条
[1]  
ALITALO K, 1984, MED BIOL, V62, P304
[2]   REARRANGEMENT OF THE TRANSCRIPTION FACTOR GENE CHOP IN MYXOID LIPOSARCOMAS WITH T(12 16)(Q13 P11) [J].
AMAN, P ;
RON, D ;
MANDAHL, N ;
FIORETOS, T ;
HEIM, S ;
ARHEDEN, K ;
WILLEN, H ;
RYDHOLM, A ;
MITELMAN, F .
GENES CHROMOSOMES & CANCER, 1992, 5 (04) :278-285
[3]   CYTOGENETIC SURVEY OF 32 CANCERS OF THE PROSTATE [J].
ARPS, S ;
RODEWALD, A ;
SCHMALENBERGER, B ;
CARL, P ;
BRESSEL, M ;
KASTENDIECK, H .
CANCER GENETICS AND CYTOGENETICS, 1993, 66 (02) :93-99
[4]  
BALABANMALENBAU.G, 1981, CANCER GENET CYTOGEN, V3, P243
[5]   CURRENT STATUS OF THE DYSPLASTIC MELANOCYTIC NEVUS [J].
BARNHILL, RL .
JOURNAL OF CUTANEOUS PATHOLOGY, 1991, 18 (03) :147-159
[6]   MOLECULAR ANALYSIS OF GENOMIC ABNORMALITIES IN HUMAN GLIOMAS [J].
BELLO, MJ ;
DECAMPOS, JM ;
KUSAK, ME ;
VAQUERO, L ;
SARASA, JL ;
PESTANA, A ;
REY, JA .
CANCER GENETICS AND CYTOGENETICS, 1994, 73 (02) :122-129
[7]   THE MOLECULAR-GENETICS OF CANCER [J].
BISHOP, JM .
SCIENCE, 1987, 235 (4786) :305-311
[8]   STATISTICAL-ANALYSIS OF CYTOGENETIC ABNORMALITIES IN HUMAN CANCER-CELLS [J].
BRODEUR, GM ;
TSIATIS, AA ;
WILLIAMS, DL ;
LUTHARDT, FW ;
GREEN, AA .
CANCER GENETICS AND CYTOGENETICS, 1982, 7 (02) :137-152
[9]  
BROZENA SJ, 1993, SEMIN SURG ONCOL, V9, P165
[10]   FREQUENT SOMATIC MUTATIONS AND HOMOZYGOUS DELETIONS OF THE P16 (MTS1) GENE IN PANCREATIC ADENOCARCINOMA [J].
CALDAS, C ;
HAHN, SA ;
DACOSTA, LT ;
REDSTON, MS ;
SCHUTTE, M ;
SEYMOUR, AB ;
WEINSTEIN, CL ;
HRUBAN, RH ;
YEO, CJ ;
KERN, SE .
NATURE GENETICS, 1994, 8 (01) :27-32